The Master's Degree in Infectious Diseases in the Emergency Department, offers you the opportunity to update your knowledge comfortably and without sacrificing scientific accuracy, in order to incorporate the latest advances in the approach to infectious diseases into your daily medical practice"

In addition to the most common infectious pathologies, in recent years new diseases have emerged which have had a great impact on public health. These have proved very complex to control and treat, including infections such as human immunodeficiency virus, the increase in bacterial resistance, infection in the context of patients with iatrogenic immunosuppression, or the exponential increase in imported tropical infectious diseases in our environment. 

In the case of infectious pathology, as in most specialties, the work of the clinician in the Emergency Department is sometimes complex and their actions are often a crucial factor in the morbidity and mortality of patients. 

Based on this premise, we believe that it is essential to establish educational tools for health professionals who have to deal with infectious diseases outside specialized units and services, and so this will be the main objective of the Master's Degree. 

We have tried to elaborate a program that includes the classic aspects in the management of infectious pathology in various apparatus or organs, obviously taking into account the most recent developments that may have occurred up to the moment the program was designed. We have also incorporated innovative aspects which we believe to be essential for correctly managing infectious diseases in the current context of globalization and health. 

We will deal with the action being taken by emergency departments against infectious diseases from the point of view of providing the earliest possible diagnosis and treatment, which is often empirical. But it will also include up-to-date information on imported pathology, especially in those cases that require urgent action and/or present a potentially high risk of transmission.

Similarly, an important part of the program will be devoted to the concept of risk prevention, stemming from infectious disease management, both for healthcare workers and the general population, and will study in depth the measures that can be adopted in Emergency Departments to minimize them. We will talk about basic action protocols in situations where there's risk of transmission of a specific infectious disease. These protocols are adapted to each center, are known by the health personnel that work there and can be implemented whenever necessary.

Seize the moment and gain up-to-date knowledge on the management of coronavirus infections"

This Master's Degree in Infectious Diseases in the Emergency Department contains the most complete and up-to-date scientific program on the market. The most important features include:

• More than 75 clinical cases presented by experts in Infectious Diseases in the Emergency Department
• The graphic, schematic, and practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
• The latest information on infectious diseases
• Practical exercises where the self-assessment process can be carried out to improve learning
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This Master's Degree is the best investment you can make when choosing an educational program for two reasons: you will obtain a Master's Degree from TECH Global University, and will acquire the best and most up-to-date knowledge in Infectious Diseases in the Emergency Department"

The teaching staff includes professionals from the field of Infectious Diseases in the Emergency Department who contribute their experience to this program, as well as renowned specialists from leading scientific societies. 
 
The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive program designed to learn in real situations.  
 
The design of this program is centered around Problem-Based Learning, in which the medical professional will resolve professional practice situations that may arise throughout the program. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced experts in the field of Infectious Diseases with extensive teaching experience. 

This is the best educational program in Infectious Diseases in the Emergency Department on the market"

Get to know all the latest information on COVID-19. Don't miss the opportunity and get up-to-date on advances in the treatment of the infections and incorporate them into your daily medical practice"

The structure of the contents has been designed by a team of professionals from leading hospitals and universities, who are aware of the relevance of up-to-date education to be able to intervene in the diagnosis, treatment and monitoring of emergency infectious diseases, and are committed to quality teaching using the latest educational technology.

This Professional Master's Degree in Infectious Diseases in the Emergency Department contains the most complete and up-to-date scientific program on the market”

Module 1. Update on Infectious Diseases

1.1. Principles of Infection

1.1.1. Virulence Factors and Toxins
1.1.2. Defensive Mechanisms of the Host

1.2. Main Human Pathogens in our Environment

1.2.1. Current Epidemiology of Infection
1.2.2. Data on a Worldwide Level
1.2.3. Microbial Resistance

1.3. Current Scenarios of Infection in the Emergency Department

1.3.1. Elderly Patients
1.3.2. Oncology Patients
1.3.3. Chronic Renal Patients on Dialysis
1.3.4. Transplant Recipient
1.3.5. HIV Infection
1.3.6. Travelers and Immigrants

1.4. Etiopathogenic Profiles of Infection

1.4.1. Bacterial Infections
1.4.2. Viral Infections
1.4.3. Fungal Infections
1.4.4. Microbacterial Infections
1.4.5. Parasitic Infections

Module 2. The Microbiology Laboratory in the Emergency Department

2.1. Process of Sample Collection

2.1.1. General Considerations for Taking, Conserving and Transporting the Samples for Microbiological Study
2.1.2. Material for Sample Collection

2.2. Management of Samples in the Laboratory

2.2.1. Receiving Samples
2.2.2. Processing 
2.2.3. Methods and Techniques Used for Microbiological Diagnosis According to the Main Infectious Syndromes

2.3. Techniques Available for Emergency Diagnoses

2.3.1. Bacteria
2.3.2. Virus
2.3.3. Fungi
2.3.4. Mycobacteria
2.3.5. Parasites

2.4. Interpretation of Preliminary Results

2.4.1. Interpretation of Microbiological Diagnostic Tests

2.5. Procedures in Hospitals Without On-call Microbiologists

2.5.1. Disadvantages of Not Having an On-call Microbiologist
2.5.2. Advantages of Having an On-call Microbiologist
2.5.3. On-call Care without a Microbiologist

Module 3. Public Health and Infectious Disease in the Emergency Department

3.1. Emergency Department Personnel

3.1.1. Initial Assessment
3.1.2. Vaccines
3.1.3. Action Protocols in Cases of Specific Exposure

3.2. Established Protocols of Isolation

3.2.1. Types of Transmission and Methods of Isolation
3.2.2. Special Situations

3.3. Notifiable Diseases and Urgent Declaration to Public Health

3.3.1. Concept of Notifiable Diseases
3.3.2. Surveillance of Notifiable Diseases

3.4. Special Situations

3.4.1. Annual Flu
3.4.2. Epidemiological Outbreaks
3.4.3. Imported Pathology Possibility of Pathology with High Contagious Capacity

3.5. Update on Epidemiological Outbreaks

3.5.1. Seasonal Epidemiological Parameters in the Most Common Infections in the Community
3.5.2. Epidemic Outbreak and Types of Source

3.6. Post-Exposure Prophylaxis that is Initiated in the Emergency Department

3.6.1. Bacterial Meningitis
3.6.2. HIV Infection
3.6.3. Sexual Assault
3.6.4. Rabies

Module 4. Systemic Febrile Syndrome. Antimicrobials

4.1. Biomarkers in Sepsis

4.1.1. Lactate
4.1.2. Procalcitonin
4.1.3. Proadrenomedulin
4.1.4. Combinations

4.2. Initial Focus in Acute Fever Syndrome

4.2.1. Initial Management of the Patient with Fever in the Emergency Department
4.2.2. Treatment
4.2.3. Special Categories
4.2.4. Fever of Unknown Origin
4.2.5. Attitude and Destiny of the Patient

4.3. Bacteremia, Sepsis and Septic Shock

4.3.1. Definitions According to Consensus Conferences
4.3.2. How to Identify a Patient with Sepsis
4.3.3. Controversies and Limitations of the New Definitions
4.3.4. Managing Sepsis

4.4. Antimicrobials

4.4.1. Concept: What is an Antimicrobial?
4.4.2. Antibacterials
4.4.3. Pregnancy and Breastfeeding
4.4.4. Antifungal

Module 5. Emergency Diagnostic and Therapeutic Management of Fever in Special Situations

5.1. Fever in the Emergency Department

5.1.1. General Concepts
5.1.2. Action Protocol
5.1.3. Patient Orientation

5.2. Fever in an Elderly Patient

5.2.1. General Concepts
5.2.2. Characteristics of the Specific Clinical Framework
5.2.3. Points to Remember

5.3. Fever in a Hemodialysis Patient

5.3.1. Infections Related to Vascular Access in Hemodialysis
5.3.2. Other Considerations in the Infectious Pathology of a Patient on Dialysis

5.4. Fever in the Patient with Intravascular Catheters

5.4.1. Clinical Manifestations
5.4.2. Etiology
5.4.3. Diagnosis
5.4.4. Treatment
5.4.5. Prevention

5.5. Patient with HIV Infection

5.5.1. Pulmonary Syndromes
5.5.2. Neurological syndromes
5.5.3. Other Fever Syndromes
5.5.4. Immune Reconstitution Syndrome

5.6. Patient with Iatrogenic Immunosuppression

5.6.1. Etiology
5.6.2. Diagnostic Approach
5.6.3. Treatment

5.7. Patient with Onco-hematologic Pathology

5.7.1. Diagnosis and Therapeutic Management of an Onco-hematologic Patient with a Fever

5.8. Transplant Recipient of a Solid Organ

5.8.1. Infections in the First Month Post-Transplant
5.8.2. Infections Between the First and Sixth Month Post-Transplant
5.8.3. Infections After the Sixth Month Post-Transplant
5.8.4. Diagnostic Strategy
5.8.5. Empirical Treatment

5.9. Patient who has Recently Undergone Surgery

5.9.1. Infection of Surgical Wounds. Current Management
5.9.2. Other Infections in a Patient who has Recently Undergone Surgery

5.10. Pregnant Patient

5.10.1. Special Characteristics of a Pregnant Woman
5.10.2. Diagnostic Orientation in the Emergency Department
5.10.3. Treatment and Management in Special Situations
5.10.4. Indications of Admission for Observation and Inpatient Treatment

Module 6. Infections of Organs and Apparatus (I): ORL, Head and Neck, Ophthalmological

6.1. Pharyngotonsillitis

6.1.1. General Concept and Classification

6.2. Oral Cavity, Head and Neck Infections

6.2.1. Plaque Gingivitis
6.2.2. GUNA
6.2.3. Oral TB
6.2.4. Oral Syphilis
6.2.5. Oral Mycosis
6.2.6. Viral Infections

6.3. Otitis Externa, Media and Mastoiditis

6.3.1. Diffuse Otitis Externa and Circumscribed Otitis Externa (Boils)
6.3.2. Otomycosis
6.3.3. Malignant Otitis Externa
6.3.4. Optic Herpes
6.3.5. Bullous Myringitis
6.3.6. Acute Otitis Media
6.3.7. Mastoiditis

6.4. Sinusitis

6.4.1. Pathophysiology
6.4.2. Classification According to Etiology and Severity
6.4.3. Symptoms
6.4.4. Diagnosis
6.4.5. Complementary Tests
6.4.6. Treatment
6.4.7. Complications

6.5. Peritonsillar, Parapharyngeal and Retropharyngeal Abscesses

6.5.1. Peritonsillar Abscess
6.5.2. Parapharyngeal Space Infection
6.5.3. Retropharyngeal Space Infection

6.6. Odontogenic Infections

6.6.1. Etiological Factors
6.6.2. Etiopathogenesis
6.6.3. Clinical Symptoms
6.6.4. Diagnosis
6.6.5. Treatment

6.7. Mucositis and Stomatitis

6.7.1. Trauma Lesions
6.7.2. Lesions Caused by Chemical Agents
6.7.3. Allergic Stomatitis
6.7.4. Oral Drug Ulcers by Unknown Mechanisms
6.7.5. Gingival Alterations Caused by Drugs
6.7.6. Facial Reaction to Aesthetic Fillers
6.7.7. Oral Lesions Caused by Cocaine
6.7.8. Oral Mucosal Dyschromias due to Exogenous Pigmentation
6.7.9. Injuries Caused by Physical Agents
6.7.10. Recurrent Aphthous Stomatitis
6.7.11. Erythema Multiform

6.8. Infection of Salivary Glands

6.8.1. General Aspects. Anamnesis and Examination Complementary Methods
6.8.2. Viral Infection
6.8.3. Bacterial Infections
6.8.4. Sialodochitis or Obstructive Pathology of the Salivary Glands

6.9. Acute Laryngitis and Epiglottitis

6.9.1. Acute Laryngitis
6.9.2. Tuberculous Laryngitis
6.9.3. Epiglottitis

6.10. Conjunctivitis and Keratitis

6.10.1. Infectious Conjunctivitis

6.10.1.1. Concept and General Considerations
6.10.1.2. Bacterial Conjunctivitis
6.10.1.3. Viral Conjunctivitis
6.10.1.4. Mycotic or Parasitic Conjunctivitis

6.10.2. Infectious Keratitis

6.10.2.1. Concept and General Considerations
6.10.2.2. Bacterial Keratitis
6.10.2.3. Viral Keratitis
6.10.2.4. Mycotic Keratitis
6.10.2.5. Acanthamoeba Keratitis

6.11. Uveitis, Endophthalmitis, and Retinitis

6.11.1. Uveitis: Concepts and Classification
6.11.2. Parasitic Uveitis
6.11.3. Viral Uveitis
6.11.4. Fungal Uveitis
6.11.5. Bacterial Uveitis

6.12. Periocular Infections

6.12.1. Stye
6.12.2. Chronic Canaliculitis
6.12.3. Acute Dacryocystitis
6.12.4. Preseptal Cellulitis
6.12.5. Postseptal (Orbital) Cellulitis
6.12.6. Acute Dacryoadenitis: Inflammation of the Lacrimal Gland
6.12.7. Viral Infections
6.12.8. Other Periocular Infections

Module 7. Infections of Organs and Apparatus (II): Skin, Soft and Osteoarticular

7.1. Cellulitis and Superficial Infections

7.1.1. Clinical Symptoms
7.1.2. Diagnosis
7.1.3. Treatment

7.2. Deep Infections

7.2.1. Necrotizing Fasciitis
7.2.2. Fournier's Gangrene
7.2.3. Infectious Myositis

7.3. Diabetic Foot

7.3.1. Etiopathogenesis
7.3.2. Clinical Symptoms
7.3.3. Staging Classification of Ulcers of Infected Diabetic Foot
7.3.4. Etiology
7.3.5. Diagnosis Complementary Evaluations
7.3.6. Treatment

7.4. Pressure Ulcers

7.4.1. Etiopathogenesis
7.4.2. Risk Factors
7.4.3. Clinical Assessment
7.4.4. Complications
7.4.5. Treatment
7.4.6. Infection of Pressure Lesions

7.5. Septic Arthritis

7.5.1. Epidemiology
7.5.2. Pathophysiology
7.5.3. Etiology
7.5.4. Clinical Symptoms
7.5.5. Diagnosis
7.5.6. Differential Diagnosis
7.5.7. Treatment
7.5.8. Prognosis

7.6. Osteomyelitis

7.6.1. Classification
7.6.2. Etiology and Clinical Characteristics
7.6.3. Diagnosis
7.6.4. Treatment

7.7. Spondylodiscitis

7.7.1. Etiopathogenesis and Microbiology
7.7.2. Clinical Manifestations
7.7.3. Diagnosis
7.7.4. Treatment
7.7.5. Prognosis

7.8. Infection of Joint Prostheses and Osteosynthesis Material

7.8.1. Etiopathogenesis
7.8.2. Diagnostic Approximation
7.8.3. Treatment Management

Module 8. Infections of Organs and Apparatus (III): Lower Airway, Intra-Abdominal

8.1. Acute Bronchitis

8.1.1. Definition
8.1.2. Clinical Manifestations
8.1.3. Diagnosis
8.1.4. Treatment

8.2. Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)

8.2.1. Definition
8.2.2. Diagnosis
8.2.3. Treatment
8.2.4. Attitude to Clinical Failure
8.2.5. Key Concepts

8.3. Community-Acquired Pneumonia (CAP)

8.3.1. Concept

8.3.2. Pathophysiology
8.3.3. Epidemiology
8.3.4. Etiology
8.3.5. Clinical Manifestations
8.3.6. Diagnostic Attitude
8.3.7. Antibiotic Treatment

8.4. Healthcare-Associated Pneumonia (HAP)

8.4.1. Concept
8.4.2. Healthcare-Associated Pneumonia Versus Community-Acquired Pneumonia due to Resistant Pathogens (CAP-PR)
8.4.3. Etiology
8.4.4. Microbiological Diagnosis
8.4.5. Empirical Treatment
8.4.6. Prognosis

8.5. Pneumonic Pleural Effusion and Empyema

8.5.1. Clinical Symptoms
8.5.2. Staging
8.5.3. Imaging Tests
8.5.4. Laboratory Studies: Pleural Fluid Analysis
8.5.5. Pathophysiology Staging
8.5.6. Bacteriology
8.5.7. Prognosis
8.5.8. Treatment

8.6. Pulmonary Abscess

8.6.1. Definition
8.6.2. Etiology
8.6.3. Pathophysiology
8.6.4. Clinical Manifestations
8.6.5. Diagnosis
8.6.6. Treatment

8.7. Pulmonary Tuberculosis

8.7.1. Etiology
8.7.2. Clinical Manifestations
8.7.3. Diagnosis
8.7.4. Treatment

8.8. Gastroenteritis

8.8.1. Etiology
8.8.2. Clinical Manifestations and Physical Examination
8.8.3. Laboratory Data and Imaging Tests
8.8.4. Diagnosis
8.8.5. Treatment

8.9. Liver and Biliary Tract Infections

8.9.1. Bacterial Infections that Affect the Liver
8.9.2. Viral Infections Which that the Liver
8.9.3. Parasitic Infections that Affect the Liver
8.9.4. Fungal Infections that Affect the Liver

8.10. Cholecystitis and Cholangitis

8.10.1. Acute Cholecystitis
8.10.2. Acute Cholangitis

8.11. Liver Abscesses

8.11.1. Concept and General Characteristics
8.11.2. Classification and Etiopathogenesis
8.11.3. Pyogenic Hepatic Abscesses
8.11.4. Amoebic Liver Abscesses

8.12. Acute Hepatitis

8.12.1. Definition
8.12.2. Etiology
8.12.3. Clinical Manifestations and Physical Examination
8.12.4. Laboratory Data
8.12.5. Diagnosis
8.12.6. Severe Acute Hepatitis
8.12.7. Severe Acute Liver Failure
8.12.8. Treatment

8.13. Pancreatitis

8.13.1. Etiology
8.13.2. Diagnosis
8.13.3. Classification
8.13.4. Severity Prediction and Prognostic
8.13.5. Treatment
8.13.6. Infectious Complications

8.14. Appendicitis

8.14.1. Epidemiology
8.14.2. Etiopathogenesis
8.14.3. Microbiology
8.14.4. Diagnosis
8.14.5. Differential Diagnosis
8.14.6. Treatment
8.14.7. Preoperative Antibiotic Prophylaxis
8.14.8. Postoperative Antibiotic Treatment
8.14.9. Post-Surgery Complications

8.15. Diverticulitis and Perirectal Abscess

8.15.1. Definition of Diverticulitis
8.15.2. Pathogenesis
8.15.3. Risk Factors
8.15.4. Diverticulitis Diagnosis
8.15.5. Diverticulitis Classification
8.15.6. Treatment for Diverticulitis
8.15.7. Perirectal Abscess

8.16. Typhlitis

8.16.1. Epidemiology
8.16.2. Etiology
8.16.3. Pathogenesis
8.16.4. Clinical Manifestations
8.16.5. Diagnosis
8.16.6. Differential Diagnosis
8.16.7. Treatment

8.17. Peritonitis

8.17.1. Classification
8.17.2. Pathogenesis
8.17.3. Diagnosis
8.17.4. Infection Severity Assessment
8.17.5. Treatment

8.18. Spontaneous Bacterial Peritonitis

8.18.1. Concept
8.18.2. Epidemiology
8.18.3. Pathogenesis
8.18.4. Clinical Manifestations
8.18.5. Diagnosis
8.18.6. Prognosis
8.18.7. Treatment
8.18.8. Prophylaxis

8.19. Secondary Peritonitis

8.19.1. Definition and Classification
8.19.2. Microbiology
8.19.3. Evaluation of Severity
8.19.4. General Principles for the Management

8.20. Intraperitoneal Abscess

8.20.1. Definition
8.20.2. Epidemiology
8.20.3. Etiology and Pathophysiology
8.20.4. Diagnosis
8.20.5. Treatment

Module 9. Infections of Organs and Apparatus (IV): Cardiovascular, CNS

9.1. Infectious Endocarditis

9.1.1. Epidemiology
9.1.2. Etiology
9.1.3. Clinical Symptoms
9.1.4. Diagnosis
9.1.5. Treatment
9.1.6. Prevention

9.2. Infection of Intravascular Devices

9.2.1. Infections Associated with Intravascular Catheter
9.2.2. Infections Related to Implantable Electronic Cardiovascular Implantable Cardiovascular Devices

9.3. Acute Pericarditis

9.3.1. Definition
9.3.2. Incessant and Chronic Pericarditis
9.3.3. Recurrent Pericarditis
9.3.4. Myopericarditis

9.4. Mediastinitis

9.4.1. Acute Mediastinitis
9.4.2. Sclerosing Mediastinitis

9.5. Meningitis

9.5.1. Epidemiology and Etiopathogenesis
9.5.2. Diagnosis of Meningitis: Clinical and Laboratory
9.5.3. Antimicrobial Treatment

9.6. Encephalitis

9.6.1. Epidemiology and Etiopathogenesis
9.6.2. Diagnosis of Encephalitis: Clinical and Complementary Evaluations
9.6.3. Antimicrobial Treatment

9.7. Myelitis

9.7.1. Epidemiology and Etiopathogenesis
9.7.2. Clinical Symptoms
9.7.3. Diagnosis
9.7.4. Treatment

9.8. Cerebral Abscess

9.8.1. Etiopathogenesis
9.8.2. Clinical Manifestations and Diagnosis
9.8.3. Treatment

9.9. Subdural Empyema, Epidural Abscess and Intracranial Thrombophlebitis

9.9.1. Subdural Empyema: Etiopathogenesis, Clinical Manifestations, Diagnosis and Treatment
9.9.2. Epidural Abscess: Etiopathogenesis, Clinical Manifestations, Diagnosis and Treatment
9.9.3. Septic Thrombophlebitis: Etiopathogenesis, Clinical Manifestations, Diagnosis and Treatment

9.10. CSF Shunt Infections

9.10.1. Etiopathogenesis
9.10.2. Clinical Manifestations
9.10.3. Diagnosis
9.10.4. Treatment

Module 10. Infections of Urinary Tract, Genitals and Sexual Transmission

10.1. Cystitis

10.1.1. Symptoms
10.1.2. Etiology
10.1.3. Diagnosis
10.1.4. Differential Diagnosis
10.1.5. Treatment

10.2. Asymptomatic Bacteriuria

10.2.1. Epidemiology
10.2.2. Pathophysiology
10.2.3. Assessment and Treatment

10.3. UTI in Patients with Bladder Catheterization

10.3.1. Etiology
10.3.2. Clinical Manifestations
10.3.3. Diagnosis
10.3.4. Prevention
10.3.5. Treatment

10.4. Prostatitis

10.4.1. Etiopathogenesis
10.4.2. Diagnosis
10.4.3. Clinical Symptoms
10.4.4. Treatment
10.4.5. Complications
10.4.6. Chronic Nonbacterial or Chronic Idiopathic Prostatitis or Chronic Pelvic Pain Syndrome

10.5. Pyelonephritis

10.5.1. Etiology
10.5.2. Clinical Manifestations
10.5.3. Complementary Tests
10.5.4. Treatment
10.5.5. Admission Criteria

10.6. Perinephritic Abscess

10.6.1. Pathophysiology
10.6.2. Clinical Symptoms
10.6.3. Etiology
10.6.4. Diagnosis
10.6.5. Assessment and Treatment

10.7. Infections which Cause Skin and Genital Mucosal Lesions

10.7.1. Bacterial Infections
10.7.2. Fungal Infections
10.7.3. Viral Infections

Module 11. Infectious Diseases in the Emergency Department of the Pediatric Patient

11.1. Fever Without Focus

11.1.1. Child With a Fever Without Focus and Poor Appearance
11.1.2. Fever Without Focus and Good General Appearance
11.1.3. Children from 3-36 Months Old With a Fever Without Focus and Good General Appearance
11.1.4. Breastfeeding Infant less than 3 Months Old With a Fever Without Focus and Good General Appearance

11.2. Sepsis and Septic Shock

11.2.1. Concept
11.2.2. Current Definition of Shock and Septic Shock
11.2.3. Etiology and Epidemiology
11.2.4. Pathophysiology
11.2.5. Risk Factors
11.2.6. Differential Diagnosis
11.2.7. Clinical Symptoms
11.2.8. Complementary Tests
11.2.9. Treatment

11.3. Fever in a Traveling Child

11.3.1. Medical History
11.3.2. Physical Examination
11.3.3. Complementary Tests
11.3.4. Treatment
11.3.5. Malaria
11.3.6. Dengue

11.4. Exanthem

11.4.1. Etiology
11.4.2. Diagnosis
11.4.3. Differential Diagnosis

11.5. Skin and Soft Tissue Infections

11.5.1. Etiopathogenesis
11.5.2. Diagnosis
11.5.3. Main Clinical Framework
11.5.4. Treatment
11.5.5. Community-Acquired Methicillin-Resistant S. Aureus

11.6. Cervical Adenitis

11.6.1. Etiology
11.6.2. Clinical Evaluation
11.6.3. Diagnosis and Treatment
11.6.4. Differential Diagnosis

11.7. Osteoarticular Infections. Acute Osteomyelitis and Septic Arthritis

11.7.1. Epidemiology
11.7.2. Etiopathogenesis
11.7.3. Clinical Symptoms
11.7.4. Diagnosis
11.7.5. Differential Diagnosis
11.7.6. Treatment

11.8. Pharyngotonsillitis and Its Complications

11.8.1. Concept
11.8.2. Epidemiology and Etiology
11.8.3. Clinical Symptoms
11.8.4. Diagnosis
11.8.5. Treatment

11.9. Otitis Media and External Sinusitis

11.9.1. Concept of Otitis Media and External

11.9.1.1. Epidemiology and Etiology
11.9.1.2. Clinical Symptoms
11.9.1.3. Complications
11.9.1.4. Diagnosis
11.9.1.5. Treatment

11.9.2. Concept of Acute Sinusitis

11.9.2.1. Epidemiology and Etiology
11.9.2.2. Clinical Symptoms
11.9.2.3. Diagnosis
11.9.2.4. Treatment

11.10. Acute Mumps

11.10.1. Epidemic Mumps
11.10.2. Vaccines
11.10.3. Prevention of Epidemic Outbreaks

11.11. Laryngitis and Epiglottitis

11.11.1. Concept
11.11.2. Epidemiology and Etiology
11.11.3. Clinical Symptoms
11.11.4. Diagnosis
11.11.5. Treatment
11.11.6. Admission Criteria

11.12. Pertussis Syndrome

11.12.1. Concept
11.12.2. Epidemiology and Etiology
11.12.3. Clinical Symptoms
11.12.4. Complications
11.12.5. Diagnosis
11.12.6. Treatment
11.12.7. Prevention

11.13. Bronchiolitis and Recurrent Wheezing Episodes

11.13.1. Acute Bronchiolitis
11.13.2. Recurrent Wheezing

11.14. Pneumonia and Complications

11.14.1. Epidemiology
11.14.2. Etiology
11.14.3. Clinical Characteristics
11.14.4. Diagnosis
11.14.5. Treatment
11.14.6. Prevention
11.14.7. Complications

11.15. TB

11.15.1. Manifestations
11.15.2. Diagnosis
11.15.3. Treatment

11.16. Acute Gastroenteritis

11.16.1. Etiopathogenesis
11.16.2. Clinical Symptoms
11.16.3. Diagnosis
11.16.4. Treatment

11.17. Viral Hepatitis

11.17.1. Assessment and Initial Management of Hepatitis in the Emergency Department
11.17.2. Classic Viral Hepatitis

11.18. Appendicitis (Need for Antibiotic or Not) and Perirectal Abscesses

11.18.1. Acute Appendicitis
11.18.2. Perirectal Abscess

11.19. Urinary Infection

11.19.1. Definition
11.19.2. Etiopathogenesis
11.19.3. Clinical Symptoms. When to Suspect a Urinary Tract Infection in the Pediatric Age Group
11.19.4. Diagnosis
11.19.5. Management

11.20. CNS Infections in Pediatrics: Acute Meningitis

11.20.1. Etiology
11.20.2. Clinical Symptoms
11.20.3. Diagnosis
11.20.4. Treatment
11.20.5. Chemoprophylaxis
11.20.6. Complications and Prognosis

11.21. Endocarditis, Myocarditis and Pericarditis

11.21.1. Infectious Endocarditis
11.21.2. Myocarditis
11.21.3. Pericarditis

11.22. Treatment in Pediatric Infectious Diseases

11.22.1. Bacterial Infections in the Pediatric Emergency Department: Diagnosis and Antibiotic Treatment of Choice, Depending on the Resistance of the Pathogens Responsible for the Disease
11.22.2. Delayed Antibiotic Prescribing Strategy
11.22.3. When is the Association of Amoxicillin with Clavulanic Acid and Macrolides Indicated in Pediatrics?
11.22.4. Do I Also Have to be Careful with Topical Antibiotherapy to Avoid Bacterial Resistance?

Module 12. Imported Infectious Diseases in the Emergency Department

12.1. Introduction to Imported Pathology

12.1.1. Imported Pathologies of Special Interest

12.1.1.1. Chagas Disease
12.1.1.2. Dengue
12.1.1.3. Chikungunya
12.1.1.4. Malaria

12.2. Globalization and Emerging Pathology

12.2.1. Emerging and Re-emerging Diseases
12.2.2. Main Causes of Emergency in Infectious Diseases
12.2.3. Transmission
12.2.4. Zoonosis
12.2.5. Future Previsions

12.3. Geography of Tropical Infectious Diseases

12.3.1. Subspecialties of Medical Geography
12.3.2. Relevance and Relationship to Tropical Diseases
12.3.3. Main Infectious Diseases According to Area

12.4. Epidemiology of Tropical Infectious Diseases in Travelers, Immigrants and VFRs

12.4.1. Importance
12.4.2. Epidemiological Characteristics of Immigrants
12.4.3. Epidemiological Characteristics of People Traveling to the Tropics
12.4.4. Epidemiological Characteristics of VFRs

12.5. Anamnesis of a Traveler with Fever in the Emergency Department

12.5.1. Initial Approximation of a Traveler with Fever
12.5.2. Differential Diagnosis
12.5.3. Treatment of a Traveler with Fever

12.6. Fever After Staying in a Tropical and/or Subtropical Area

12.6.1. Importance of Good Anamnesis
12.6.2. Investigation of Possible Vectors
12.6.3. Fever of Parasitic Origin
12.6.4. Fever of Viral Origin
12.6.5. Fever of Bacterial Origin
12.6.6. Other Causes of Fever

12.7. Imported Infectious Pathology. Syndrome Classification

12.7.1. Fever and Cutaneous Lesion
12.7.2. Fever and Altered Level of Consciousness
12.7.3. Fever and Liver Problems
12.7.4. Fever and Respiratory Semiology
12.7.5. Fever and Digestive Semiology

12.8. Imported Tropical Infectious Diseases of Special Interest

12.8.1. Malaria
12.8.2. Arbovirus: Dengue, Zika, Chikungunya
12.8.3. MERS Coronavirus (MERS CoV)
12.8.4. Schistosomiasis
12.8.5. Invasive Enteritis (Salmonella, Shigella, E.coli, Campylobacter)
12.8.6. Hemorrhagic Fevers (Ebola, Lassa, Marburg, Yellow Fever, Crimean-Congo)

Module 13. Latest Information on Coronavirus Infections

13.1. Discovery and Evolution of Coronaviruses

13.1.1. Discovery of Coronaviruses
13.1.2. Global Trends in Coronavirus Infections

13.2. Main Microbiological characteristics and Members of the Coronavirus Family

13.2.1. General Microbiological Characteristics of Coronaviruses
13.2.2. Viral Genome
13.2.3. Principal Virulence Factors

13.3. Epidemiological Changes in Coronavirus Infections from Discovery to the Present

13.3.1. Morbidity and Mortality of Coronavirus Infections from their Emergence to the Present

13.4. The Immune System and Coronavirus Infections

13.4.1. Immunological Mechanisms Involved in the Immune Response to Coronaviruses
13.4.2. Cytokine Storm in Coronavirus Infections and Immunopathology
13.4.3. Modulation of the Immune System in Coronavirus Infections

13.5. Pathogenesis and Pathophysiology of Coronavirus Infections

13.5.1. Pathophysiological and Pathogenic Alterations in Coronavirus Infections
13.5.2. Clinical Implications of the Main Pathophysiological Alterations

13.6. Risk Groups and Transmission Mechanisms of Coronaviruses

13.6.1. Main Sociodemographic and Epidemiological Characteristics of Risk Groups Affected by Coronavirus
13.6.2. Coronavirus Mechanisms of Transmission

13.7. Natural History of Coronavirus Infections

13.7.1. Stages of Coronavirus Infection

13.8. Latest Information on Microbiological Diagnosis of Coronavirus Infections

13.8.1. Sample Collection and Shipment
13.8.2. PCR and Sequencing
13.8.3. Serology Testing
13.8.4. Virus Isolation

13.9. Current Biosafety Measures in Microbiology Laboratories for Coronavirus Sample Handling

13.9.1. Biosafety Measures for Coronavirus Sample Handling

13.10. Up-to-Date Management of Coronavirus Infections

13.10.1. Prevention Measures
13.10.2. Symptomatic Treatment
13.10.3. Antiviral and Antimicrobial Treatment in Coronavirus Infections
13.10.4. Treatment of Severe Clinical Forms

13.11. Future Challenges in the Prevention, Diagnosis, and Treatment of Coronavirus

13.11.1. Global Challenges for the Development of Prevention, Diagnostic, and Treatment Strategies for Coronaviru

This Master's Degree in Infectious Diseases in the Emergency Department contains the most complete and up to date scientific program on the market”